FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Gaynon

Research Profile

Disorders

Living Beings

Infants

Procedures

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

Anatomy

Bone Marrow

Co-author Network

Publications

TOP 3
Sara C Acree; Joseph A Church; Paul S Gaynon; Paul K Pattengale; Jason P Tovar; Larry L Wang; David S Cassarino
Subcutaneous Panniculitis-Like T-Cell Lymphoma in Two Pediatric Patients: An HIV-Positive Adolescent and a 4-Month-Old Infant.
Paul S Gaynon; Theresa M Harned
ABT-751 in relapsed childhood acute lymphoblastic leukemia.
Leonard A Mattano; James B Nachman; Harland N Sather; Nita L Seibel; Peter G Steinherz; Meenakshi Devidas; Paul S Gaynon; Stephen P Hunger
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Gaynon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sara C Acree; Joseph A Church; Paul S Gaynon; Paul K Pattengale; Jason P Tovar; Larry L Wang; David S Cassarino
Subcutaneous Panniculitis-Like T-Cell Lymphoma in Two Pediatric Patients: An HIV-Positive Adolescent and a 4-Month-Old Infant.
Fetal and pediatric pathology 2013;32(3):175-83.
2012: Paul S Gaynon; Theresa M Harned
ABT-751 in relapsed childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology 2012;34(7):583-4.
2012: Leonard A Mattano; James B Nachman; Harland N Sather; Nita L Seibel; Peter G Steinherz; Meenakshi Devidas; Paul S Gaynon; Stephen P Hunger
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
The lancet oncology 2012;13(9):906-15.
2012: Yoav H Messinger; Richard Sposto; Jeannette van der Giessen; Bruce C Bostrom; Elena Eckroth; Paul S Gaynon; Jemily Malvar
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Blood 2012;120(2):285-90.
2012: Stephen P Hunger; Xiaomin Lu; Gregory H Reaman; Naomi J Winick; Bruce M Camitta; Meenakshi Devidas; Paul S Gaynon; William L Carroll
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(14):1663-9.
2012: Martin Schrappe; Lewis B Silverman; Anne Birgitta Versluys; André Baruchel; Bruce M Camitta; Valentino Conter; Meenakshi Devidas; Gabriele Escherich; Paul S Gaynon; Jochen Harbott; Mats Heyman; Keizo Horibe; Stephen P Hunger; Georg Mann; Akira Ohara; Jacques Otten; Ching-Hon Pui; Sue Richards; Hansjörg Riehm; Vaskar Saha; Martin Zimmermann
Outcomes after induction failure in childhood acute lymphoblastic leukemia.
The New England journal of medicine 2012;366(15):1371-81.
2011: Nobuko Hijiya; Michael S Isakoff; Sima Jeha; Richard Kadota; Kelly Maloney; Jo-Anne Paul; Violet Shen; Lewis B Silverman; Peter G Steinherz; Blythe Thomson; Jaideep V Thottassery; Elly Barry; Michael J Borowitz; William L Carroll; Todd Cooper; Gary Dahl; Paul S Gaynon
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Blood 2011;118(23):6043-9.
2011: Paul S Gaynon
A remembrance: James B. Nachman 1948-2011.
Pediatric blood & cancer 2011;57(4):533-4.
2011: Paul S Gaynon
James B. Nachman, 1948 to 2011: a remembrance.
Journal of pediatric hematology/oncology 2011;33(6):403-5.
2011: Peter L Bonate; Casey C Cunningham; Paul S Gaynon; Sima Jeha; Richard Kadota; Gilbert N Lam; Bassem I Razzouk; Michael Rytting; Peter G Steinherz; Steven D Weitman
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
Cancer chemotherapy and pharmacology 2011;67(4):875-90.
2011: David R Freyer; Meenakshi Devidas; Mei La; William L Carroll; Paul S Gaynon; Stephen P Hunger; Nita L Seibel
Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.
Blood 2011;117(11):3010-5.
2010: Matthew F Gorman; Lingyun Ji; Richard H Ko; Phillip Barnette; Bruce C Bostrom; Raymond J Hutchinson; Elizabeth Raetz; Nita L Seibel; Clare J Twist; Elena Eckroth; Richard Sposto; Paul S Gaynon; Mignon L Loh
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.
Pediatric blood & cancer 2010;55(3):421-9.
2010: Terzah M Horton; Richard Sposto; Patrick Brown; Charles Patrick Reynolds; Stephen P Hunger; Naomi J Winick; Elizabeth A Raetz; William L Carroll; Robert J Arceci; Michael J Borowitz; Paul S Gaynon; Lia Gore; Sima Jeha; Barry J Maurer; Stuart E Siegel; Andrea Biondi; Pamela R Kearns; Aru Narendran; Lewis B Silverman; Malcolm A Smith; C Michel Zwaan; James A Whitlock
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference.
Pediatric blood & cancer 2010;54(7):872-8.
2010: Linda C Stork; Yousif Matloub; Emmett Broxson; Mei K La; Rochelle Yanofsky; Harland Sather; Raymond J Hutchinson; Nyla A Heerema; April D Sorrell; Margaret Masterson; Archie Bleyer; Paul S Gaynon
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
Blood 2010;115(14):2740-8.
2010: Paul S Gaynon; A L Angiolillo; William L Carroll; James B Nachman; Michael E Trigg; Harland Sather; Stephen P Hunger; M Devidas
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.
Leukemia 2010;24(2):285-97.
2010: Richard H Ko; Lingyun Ji; Phillip Barnette; Bruce C Bostrom; Raymond J Hutchinson; Elizabeth Raetz; Nita L Seibel; Clare J Twist; Elena Eckroth; Richard Sposto; Paul S Gaynon; Mignon L Loh
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):648-54.
2009: Saro H Armenian; Kevin A Nash; Neena Kapoor; Janet L Franklin; Paul S Gaynon; Lawrence A Ross; Jill A Hoffman
Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Journal of pediatric hematology/oncology 2009;31(12):920-6.
2009: N Hijiya; Paul S Gaynon; E Barry; L Silverman; B Thomson; R Chu; T Cooper; R Kadota; M Rytting; Peter G Steinherz; V Shen; S Jeha; R Abichandani; William L Carroll
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.
Leukemia 2009;23(12):2259-64.
2009: James B Nachman; Mei K La; Stephen P Hunger; Nyla A Heerema; Paul S Gaynon; Caroline Hastings; Leonard A Mattano; Harland Sather; Meenakshi Devidas; David R Freyer; Peter G Steinherz; Nita L Seibel
Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5189-94.
2009: Kirk R Schultz; W Paul Bowman; Alexander Aledo; William B Slayton; Harland Sather; Meenakshi Devidas; Chenguang Wang; Stella M Davies; Paul S Gaynon; Michael E Trigg; Robert Rutledge; Laura Burden; Dean Jorstad; Andrew Carroll; Nyla A Heerema; Naomi J Winick; Michael J Borowitz; Stephen P Hunger; William L Carroll; Bruce Camitta
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5175-81.
2009: Sima Jeha; Bassem I Razzouk; Michael Rytting; Susan Rheingold; Edythe Albano; Richard Kadota; Lori Luchtman-Jones; Lisa R Bomgaars; Paul S Gaynon; Stewart Goldman; Kim Ritchey; Robert J Arceci; Arnold Altman; Kimo Stine; Laurel Steinherz; Peter G Steinherz
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4392-7.
2009: Richard Sposto; Paul S Gaynon
An adjustment for patient heterogeneity in the design of two-stage phase II trials.
Statistics in medicine 2009;28(20):2566-79.
2008: Wendy Stock; Mei La; Ben Sanford; Clara D Bloomfield; James W Vardiman; Paul S Gaynon; Richard A Larson; James B Nachman
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Blood 2008;112(5):1646-54.
2008: Elizabeth A Raetz; Michael J Borowitz; Meenakshi Devidas; Stephen B Linda; Stephen P Hunger; Naomi J Winick; Bruce M Camitta; Paul S Gaynon; William L Carroll
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):3971-8.
2008: Michael E Trigg; Harland N Sather; Gregory H Reaman; David G Tubergen; Peter G Steinherz; Paul S Gaynon; fatih uckun; G Denman Hammond
Ten-year survival of children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Leukemia & lymphoma 2008;49(6):1142-54.
2008: Theresa M Harned; Paul S Gaynon
Treating refractory leukemias in childhood, role of clofarabine.
Therapeutics and clinical risk management 2008;4(2):327-36.
2008: Nita L Seibel; Peter G Steinherz; Harland Sather; James B Nachman; Cynthia Delaat; Lawrence J Ettinger; David R Freyer; Leonard A Mattano; Caroline A Hastings; Charles M Rubin; Kathy Bertolone; Janet L Franklin; Nyla A Heerema; Torrey L Mitchell; Allan F Pyesmany; Mei K La; Cheryl Edens; Paul S Gaynon
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2008;111(5):2548-55.
2007: Suman Malempati; Paul S Gaynon; Harland Sather; Mei K La; Linda C Stork
Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5800-7.
2007: Paul S Gaynon
Treatment of pediatric acute lymphoblastic leukemia: progress achieved and challenges remaining.
Current hematologic malignancy reports 2007;2(3):193-201.
2007: Nyla A Heerema; Susana C Raimondi; James Robert Anderson; Jaclyn Biegel; Bruce M Camitta; Linda D Cooley; Paul S Gaynon; Betsy Hirsch; R Ellen Magenis; Loris McGavran; Shivanand Patil; Mark J Pettenati; Jeanette Pullen; Kathleen W Rao; Diane Roulston; Nancy R Schneider; Jonathan J Shuster; Warren G Sanger; Maxine J Sutcliffe; Peter van Tuinen; Michael S Watson; Andrew J Carroll
Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia.
Genes, chromosomes & cancer 2007;46(7):684-93.
2007: Anna M Butturini; Frederick J Dorey; Beverly J Lange; David W Henry; Paul S Gaynon; Cecilia Fu; Janet Franklin; Stuart E Siegel; Nita L Seibel; Paul C Rogers; Harland Sather; Michael E Trigg; Archie Bleyer; William L Carroll
Obesity and outcome in pediatric acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2063-9.
2007: Kirk R Schultz; D Jeanette Pullen; Harland Sather; Jonathan J Shuster; Meenakshi Devidas; Michael J Borowitz; Andrew J Carroll; Nyla A Heerema; Jeffrey E Rubnitz; Mignon L Loh; Elizabeth A Raetz; Naomi J Winick; Stephen P Hunger; William L Carroll; Paul S Gaynon; Bruce M Camitta
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Blood 2007;109(3):926-35.
2006: Yousif Matloub; Susan J Lindemulder; Paul S Gaynon; Harland Sather; Mei K La; Emmett Broxson; Rochelle Yanofsky; Raymond J Hutchinson; Nyla A Heerema; James B Nachman; Marilyn Blake; Linda M Wells; April D Sorrell; Margaret Masterson; John F Kelleher; Linda C Stork
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
Blood 2006;108(4):1165-73.
2006: Mohammad Jarrar; Paul S Gaynon; Antonia P Periclou; Cecilia Fu; Richard E Harris; Daniel Stram; Arnold Altman; Bruce C Bostrom; John C. Breneman; David Steele; Michael E Trigg; Theodore Zipf; Vassilios I Avramis
Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).
Pediatric blood & cancer 2006;47(2):141-6.
2006: Paul S Gaynon; Richard E Harris; Arnold J Altman; Bruce C Bostrom; John C. Breneman; Ria Hawks; David Steele; Theodore Zipf; Daniel O Stram; Doojduen Villaluna; Michael E Trigg
Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3150-6.
2006: Sima Jeha; Paul S Gaynon; Bassem I Razzouk; Janet Franklin; Richard Kadota; Violet Shen; Lori Luchtman-Jones; Michael Rytting; Lisa R Bomgaars; Susan Rheingold; Kim Ritchey; Edythe Albano; Robert J Arceci; Stewart Goldman; Timothy Griffin; Arnold Altman; Bruce Gordon; Laurel Steinherz; Steven D Weitman; Peter G Steinherz
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1917-23.
2006: Paul S Gaynon
Treatment adherence and 6-mercaptopurine metabolites.
Pediatric blood & cancer 2006;46(2):120-1.
2006: Theresa Hahn; Donna Wall; Bruce M Camitta; Stella Davies; Hildy Dillon; Paul S Gaynon; Richard A Larson; Susan K Parsons; Jerome Seidenfeld; Daniel Weisdorf; Philip L McCarthy
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1):1-30.
2005: James A Whitlock; Harland Sather; Paul S Gaynon; Leslie L Robison; Robert J Wells; Michael E Trigg; Nyla A Heerema; Smita Bhatia
Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 2005;106(13):4043-9.
2005: Paul S Gaynon
Childhood acute lymphoblastic leukaemia and relapse.
British journal of haematology 2005;131(5):579-87.
2005: Theresa Hahn; Donna Wall; Bruce M Camitta; Stella Davies; Hildy Dillon; Paul S Gaynon; Richard A Larson; Susan K Parsons; Jerome Seidenfeld; Daniel Weisdorf; Philip L McCarthy
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(11):823-61.
2005: Stacey L Berg; Susan M Blaney; Meenakshi Devidas; Tom A Lampkin; Anthony J Murgo; Mark Bernstein; Amy L Billett; Joanne Kurtzberg; Gregory Reaman; Paul S Gaynon; James A Whitlock; Mark Krailo; Michael B Harris
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3376-82.
2005: Anthony V Moorman; Susana C Raimondi; Ching-Hon Pui; A Baruchel; A Biondi; Andrew J Carroll; E Forestier; Paul S Gaynon; Jochen Harbott; Dieter Harms; Nyla A Heerema; R Pieters; Martin Schrappe; Lewis B Silverman; E Vilmer; Christine J Harrison
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities.
Leukemia 2005;19(4):557-63.
2005: Mylène Bassal; Mei K La; James A Whitlock; Harland Sather; Nyla A Heerema; Paul S Gaynon; Linda C Stork
Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
Pediatric blood & cancer 2005;44(1):21-8.
2004: Peter L Bonate; Adam Craig; Paul S Gaynon; Varsha Gandhi; Sima Jeha; Richard Kadota; Gilbert N Lam; William Plunkett; Bassem I Razzouk; Michael Rytting; Peter G Steinherz; Steven D Weitman
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
Journal of clinical pharmacology 2004;44(11):1309-22.
2004: Giuseppe Masera; Tim Eden; Martin Schrappe; James B Nachman; Helmut Gadner; Paul S Gaynon; William Evans; Ching-Hon Pui
Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia.
Pediatric blood & cancer 2004;43(2):103-4.
2004: Nyla A Heerema; James B Nachman; Harland Sather; Mei K La; Raymond J Hutchinson; Beverly J Lange; Bruce C Bostrom; Peter G Steinherz; Paul S Gaynon; fatih uckun
Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.
Leukemia 2004;18(5):939-47.
2004: Eduard H Panosyan; Nita L Seibel; Sagrario Martin-Aragon; Paul S Gaynon; Ioannis A Avramis; Harland Sather; Janet Franklin; James B Nachman; Lawrence J Ettinger; Mei K La; Peter G Steinherz; Lewis J Cohen; Stuart E Siegel; Vassilios I Avramis
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.
Journal of pediatric hematology/oncology 2004;26(4):217-26.
2004: Nyla A Heerema; Jochen Harbott; S Galimberti; Bruce M Camitta; Paul S Gaynon; Gritta E Janka-Schaub; W Kamps; G Basso; Ching-Hon Pui; Martin Schrappe; M-F Auclerc; Andrew J Carroll; Valentino Conter; Christine J Harrison; Jeanette Pullen; Susana C Raimondi; S Richards; Hansjörg Riehm; Harland Sather; Jonathan J Shuster; Lewis B Silverman; M G Valsecchi; M Aricò
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Leukemia 2004;18(4):693-702.
2004: John P Perentesis; Smita Bhatia; E Boyle; Y Shao; X Ou Shu; M Steinbuch; Harland Sather; Paul S Gaynon; William R Kiffmeyer; J Envall-Fox; Leslie L Robison
RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.
Leukemia 2004;18(4):685-92.
2004: Eduard H Panosyan; Rita S Grigoryan; Ioannis A Avramis; Nita L Seibel; Paul S Gaynon; Stuart E Siegel; Howard J Fingert; Vassilios I Avramis
Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).
Anticancer research 2004;24(2C):1121-5.
2004: Rita S Grigoryan; Eduard H Panosyan; Nita L Seibel; Paul S Gaynon; Ioannis A Avramis; Vassilios I Avramis
Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961).
In vivo (Athens, Greece) 2004;18(2):107-12.
2003: Gregor S D Reid; Luke Terrett; Angela J Alessandri; Stacey Grubb; Linda C Stork; Nita L Seibel; Paul S Gaynon; Kirk R Schultz
Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells.
Leukemia research 2003;27(12):1135-42.
2003: Adam Levy; Harland Sather; Peter G Steinherz; Rebecca Sowers; Mei K La; Jeffrey A Moscow; Paul S Gaynon; fatih uckun; Joseph R Bertino; Richard Gorlick
Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study.
Journal of pediatric hematology/oncology 2003;25(9):688-95.
2003: Shi-Qi Wu; Kenneth I Weinberg; Wan Jong Joo; John J Quinn; Janet Franklin; Stuart E Siegel; Paul S Gaynon
Preponderant mitotic activity of nonleukemic cells plays an important role in failures to detect abnormal clone in childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology 2003;25(7):520-5.
2003: Bruce C Bostrom; Martha R Sensel; Harland Sather; Paul S Gaynon; Mei K La; Katherine Johnston; Gary R Erdmann; Stuart Gold; Nyla A Heerema; Raymond J Hutchinson; Arthur J Provisor; Michael E Trigg
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 2003;101(10):3809-17.
2003: Raymond J Hutchinson; Paul S Gaynon; Harland Sather; Salvatore J Bertolone; Herbert Cooper; Raymond Tannous; Linda M Wells; Nyla A Heerema; Scott Sailer; Michael E Trigg
Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1790-7.
2002: Smita Bhatia; Harland Sather; Nyla A Heerema; Michael E Trigg; Paul S Gaynon; Leslie L Robison
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.
Blood 2002;100(6):1957-64.
2002: Paul S Gaynon
Response to Donadieu and Hill "Clinical trials in childhood acute lymphoblastic leukemia: a common prognostic classification and a common induction therapy are now warranted".
Journal of pediatric hematology/oncology 2002;24(6):426-8.
2002: Stella M Davies; Smita Bhatia; Julie A Ross; William R Kiffmeyer; Paul S Gaynon; Gretchen A Radloff; Leslie L Robison; John P Perentesis
Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia.
Blood 2002;100(1):67-71.
2002: Smita Bhatia; Harland Sather; Olga B Pabustan; Michael E Trigg; Paul S Gaynon; Leslie L Robison
Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.
Blood 2002;99(12):4257-64.
2002: Ching-Hon Pui; Paul S Gaynon; James M Boyett; Judith M Chessells; André Baruchel; Willem Kamps; Lewis B Silverman; Andrea Biondi; Dieter Harms; Etienne Vilmer; Martin Schrappe; Bruce M Camitta
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.
Lancet 2002;359(9321):1909-15.
2002: Vassilios I Avramis; Susan F Sencer; Antonia P Periclou; Harland Sather; Bruce C Bostrom; Lewis J Cohen; Alice G Ettinger; Lawrence J Ettinger; Janet Franklin; Paul S Gaynon; Joanne M Hilden; Beverly Lange; Fataneh Majlessipour; Pracad Mathew; Michael Neil Needle; Joseph P Neglia; Gregory Reaman; John Holcenberg; Linda C Stork
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 2002;99(6):1986-94.
2002: Helen A Kurre; Alice G Ettinger; David L Veenstra; Paul S Gaynon; Janet Franklin; Susan F Sencer; Gregory H Reaman; Beverly J Lange; John Holcenberg
A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962).
Journal of pediatric hematology/oncology 2002;24(3):175-81.
2002: Paul S Gaynon
From where do clinical trials come?
Journal of pediatric hematology/oncology 2002;24(3):172-4.
2002: Nyla A Heerema; Harland Sather; Martha G Sensel; Mei K La; Raymond J Hutchinson; James B Nachman; Gregory H Reaman; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Paul S Gaynon; fatih uckun
Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia.
Cancer 2002;94(4):1102-10.
2001: fatih uckun; N Pallisgaard; Peter Hokland; Christopher S Navara; Rama Krishna Narla; Paul S Gaynon; Harland Sather; Nyla A Heerema
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
Leukemia & lymphoma 2001;42(1-2):41-56.
2001: Paul S Gaynon; Bruce C Bostrom; Raymond J Hutchinson; Beverly J Lange; James B Nachman; Peter G Steinherz; Martha G Sensel; M K Lee; D O Stram; Harland Sather
Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1916-25.
2001: fatih uckun; Paul S Gaynon; D O Stram; Martha G Sensel; MB Sarquis; ML Willoughby
Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Leukemia & lymphoma 2001;40(3-4):279-85.
2000: Paul S Gaynon; Michael E Trigg; N A Heerema; Martha G Sensel; Harland Sather; G D Hammond; Archie Bleyer
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.
Leukemia 2000;14(12):2223-33.
2000: N A Heerema; Harland Sather; Martha G Sensel; M K Lee; Raymond J Hutchinson; James B Nachman; Gregory H Reaman; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Paul S Gaynon; fatih uckun
Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3837-44.
2000: fatih uckun; Linda C Stork; Nita L Seibel; MB Sarquis; C Bedros; Harland Sather; Martha G Sensel; Gregory H Reaman; Paul S Gaynon
Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3123-30.
2000: N A Heerema; Harland Sather; Martha G Sensel; T Zhang; Raymond J Hutchinson; James B Nachman; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Gregory H Reaman; Paul S Gaynon; fatih uckun
Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1876-87.
2000: Nyla A Heerema; Harland Sather; Martha G Sensel; MK Lee; Raymond J Hutchinson; James B Nachman; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Paul S Gaynon; fatih uckun
Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Cancer 2000;88(8):1945-54.
2000: Nyla A Heerema; Harland Sather; Martha G Sensel; MK Lee; Raymond J Hutchinson; Beverly J Lange; Bruce C Bostrom; James B Nachman; Peter G Steinherz; Paul S Gaynon; fatih uckun
Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Leukemia & lymphoma 2000;36(5-6):467-78.
2000: Michael E Trigg; Peter G Steinherz; R Chappell; Helen S Johnstone; Paul S Gaynon; John H Kersey; Joel M Cherlow; N J Grossman; Harland Sather; G D Hammond
Early testicular biopsy in males with acute lymphoblastic leukemia: lack of impact on subsequent event-free survival.
Journal of pediatric hematology/oncology 2000;22(1):27-33.
1999: Nyla A Heerema; James B Nachman; Harland Sather; Martha G Sensel; MK Lee; Raymond J Hutchinson; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Paul S Gaynon; fatih uckun
Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group.
Blood 1999;94(12):4036-45.
1999: L Sun; Patricia A Goodman; C M Wood; ML Crotty; Martha G Sensel; Harland Sather; Christopher S Navara; James B Nachman; Peter G Steinherz; Paul S Gaynon; Nita L Seibel; Alexei O Vassilev; B D Juran; Gregory H Reaman; fatih uckun
Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3753-66.
1999: fatih uckun; Paul S Gaynon; D O Stram; Martha G Sensel; MB Sarquis; K H Lazarus; ML Willoughby
Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2415-20.
1999: Nyla A Heerema; Harland Sather; Martha G Sensel; Wen Liu; Beverly J Lange; Bruce C Bostrom; James B Nachman; Peter G Steinherz; Raymond J Hutchinson; Paul S Gaynon; Diane C Arthur; fatih uckun
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group.
Blood 1999;94(5):1537-44.
1999: L Sun; ML Crotty; Martha G Sensel; Harland Sather; Christopher S Navara; James B Nachman; Peter G Steinherz; Paul S Gaynon; Nita L Seibel; C Mao; Alexei O Vassilev; Gregory H Reaman; fatih uckun
Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2112-20.
1999: fatih uckun; James B Nachman; Harland Sather; Martha G Sensel; P Kraft; Peter G Steinherz; B Lange; Raymond J Hutchinson; Gregory H Reaman; Paul S Gaynon; Nyla A Heerema
Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
Leukemia & lymphoma 1999;33(1-2):101-6.
1999: Gregory H Reaman; Richard Sposto; Martha G Sensel; Beverly J Lange; James Feusner; Nyla A Heerema; M Leonard; Emiko J Holmes; Harland Sather; T W Pendergrass; Helen S Johnstone; R T O'Brien; Peter G Steinherz; Paul M Zeltzer; Paul S Gaynon; Michael E Trigg; fatih uckun
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):445-55.
1999: fatih uckun; Barbara Waurzyniak; Harland Sather; Martha G Sensel; LM Chelstrom; James B Nachman; Paul S Gaynon; Bruce C Bostrom; O Ek; MB Sarquis; Peter G Steinherz; Gregory H Reaman
Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study.
Leukemia & lymphoma 1999;32(5-6):475-87.
1999: I P Moskowitz; Paul S Gaynon; N T Shahidi; Timothy P Cripe
Low-dose cyclosporin A therapy in children with refractory immune thrombocytopenic purpura.
Journal of pediatric hematology/oncology 1999;21(1):77-9.
1998: Barbara Waurzyniak; Nyla A Heerema; Martha G Sensel; Paul S Gaynon; P Kraft; Harland Sather; LM Chelstrom; Gregory H Reaman; fatih uckun
Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.
Leukemia & lymphoma 1998;32(1-2):77-87.
1998: fatih uckun; James B Nachman; Harland Sather; Martha G Sensel; P Kraft; Peter G Steinherz; B Lange; Raymond J Hutchinson; Gregory H Reaman; Paul S Gaynon; Nyla A Heerema
Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group.
Cancer 1998;83(9):2030-9.
1998: O Ek; Paul S Gaynon; T Zeren; LM Chelstrom; DE Myers; fatih uckun
Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase.
Leukemia & lymphoma 1998;31(1-2):143-9.
1998: fatih uckun; Harland Sather; Barbara Waurzyniak; Martha G Sensel; LM Chelstrom; O Ek; MB Sarquis; James B Nachman; Bruce C Bostrom; Gregory H Reaman; Paul S Gaynon
Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study.
Leukemia & lymphoma 1998;30(5-6):503-14.
1998: fatih uckun; K Herman-Hatten; ML Crotty; Martha G Sensel; Harland Sather; L Tuel-Ahlgren; MB Sarquis; Bruce C Bostrom; James B Nachman; Peter G Steinherz; Paul S Gaynon; Nyla A Heerema
Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
Blood 1998;92(3):810-21.
1998: fatih uckun; Barbara Waurzyniak; Martha G Sensel; LM Chelstrom; ML Crotty; Paul S Gaynon; Gregory H Reaman
Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.
Leukemia & lymphoma 1998;30(3-4):269-77.
1998: James B Nachman; Harland Sather; Martha G Sensel; Michael E Trigg; Joel M Cherlow; John Lukens; L Wolff; fatih uckun; Paul S Gaynon
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
The New England journal of medicine 1998;338(23):1663-71.
1998: Nyla A Heerema; Harland Sather; Martha G Sensel; P Kraft; James B Nachman; Peter G Steinherz; Beverly J Lange; Raymond J Hutchinson; Gregory H Reaman; Michael E Trigg; Diane C Arthur; Paul S Gaynon; fatih uckun
Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1270-8.
1998: Paul S Gaynon; R P Qu; R J Chappell; ML Willoughby; DG Tubergen; Peter G Steinherz; Michael E Trigg
Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group Experience.
Cancer 1998;82(7):1387-95.
1998: James B Nachman; Harland Sather; Joel M Cherlow; Martha G Sensel; Paul S Gaynon; John Lukens; L Wolff; Michael E Trigg
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):920-30.
1998: fatih uckun; Martha G Sensel; Harland Sather; Paul S Gaynon; Diane C Arthur; Beverly J Lange; Peter G Steinherz; P Kraft; Raymond J Hutchinson; James B Nachman; Gregory H Reaman; Nyla A Heerema
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):527-35.
1998: Peter G Steinherz; Paul S Gaynon; John C. Breneman; Joel M Cherlow; N J Grossman; John H Kersey; Helen S Johnstone; Harland Sather; Michael E Trigg; fatih uckun; Archie Bleyer
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Cancer 1998;82(3):600-12.
1998: fatih uckun; Martha G Sensel; L Sun; Peter G Steinherz; Michael E Trigg; Nyla A Heerema; Harland Sather; Gregory H Reaman; Paul S Gaynon
Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.
Blood 1998;91(3):735-46.
1997: fatih uckun; Harland Sather; Paul S Gaynon; D Arthur; James B Nachman; Martha G Sensel; Peter G Steinherz; Raymond J Hutchinson; Michael E Trigg; Gregory Reaman
Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Leukemia & lymphoma 1997;27(5-6):445-57.
1997: Paul S Gaynon; A A Desai; Bruce C Bostrom; Raymond J Hutchinson; Beverly J Lange; James B Nachman; Gregory H Reaman; Harland Sather; Peter G Steinherz; Michael E Trigg; DG Tubergen; fatih uckun
Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review.
Cancer 1997;80(9):1717-26.
1997: Lawrence J Ettinger; P Ivy; Paul S Gaynon; Alice G Ettinger; Wen Liu; Mark Krailo
A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group.
Cancer 1997;80(2):311-6.
1997: fatih uckun; Harland Sather; Paul S Gaynon; Diane C Arthur; Michael E Trigg; DG Tubergen; James B Nachman; Peter G Steinherz; Martha G Sensel; Gregory H Reaman
Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 1997;90(1):28-35.
1997: Kirk R Schultz; Bonnie G Massing; John Spinelli; Paul S Gaynon; Louis D Wadsworth
Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia.
Medical and pediatric oncology 1997;29(1):16-22.
1997: Paul S Gaynon; ML Crotty; Harland Sather; Bruce C Bostrom; James B Nachman; Peter G Steinherz; Nyla A Heerema; MB Sarquis; L Tuel-Ahlgren; fatih uckun
Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiative.
Leukemia & lymphoma 1997;26(1-2):57-65.
1997: James B Nachman; Harland Sather; Paul S Gaynon; John Lukens; L Wolff; Michael E Trigg
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2222-30.
1997: fatih uckun; Paul S Gaynon; Martha G Sensel; James B Nachman; Michael E Trigg; Peter G Steinherz; Raymond J Hutchinson; Bruce C Bostrom; Harland Sather; Gregory H Reaman
Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2214-21.
1997: fatih uckun; Z Yang; Harland Sather; Peter G Steinherz; James B Nachman; Bruce C Bostrom; L Crotty; MB Sarquis; O Ek; T Zeren; DG Tubergen; Gregory Reaman; Paul S Gaynon
Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Blood 1997;89(10):3769-77.
1997: fatih uckun; Paul S Gaynon; Harland Sather; D Arthur; Michael E Trigg; DG Tubergen; James B Nachman; Peter G Steinherz; Martha G Sensel; G R Reaman
Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 1997;89(7):2488-93.
1997: Lawrence J Ettinger; Alice G Ettinger; Vassilios I Avramis; Paul S Gaynon
Acute lymphoblastic leukaemia: a guide to asparaginase and pegaspargase therapy.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1997;7(1):30-9.
1996: fatih uckun; Gregory Reaman; P G Steinherez; Diane C Arthur; Harland Sather; Michael E Trigg; DG Tubergen; Paul S Gaynon
Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study.
Leukemia & lymphoma 1996;24(1-2):57-70.
1996: fatih uckun; Peter G Steinherz; Harland Sather; Michael E Trigg; D Arthur; DG Tubergen; Paul S Gaynon; Gregory Reaman
CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 1996;88(11):4288-95.
1996: Joel M Cherlow; Harland Sather; Peter G Steinherz; Paul S Gaynon; DG Tubergen; Michael E Trigg; L Novak; Archie Bleyer
Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group.
International journal of radiation oncology, biology, physics 1996;36(1):19-27.
1996: Peter G Steinherz; Paul S Gaynon; John C. Breneman; Joel M Cherlow; N J Grossman; J H Kersey; Helen S Johnstone; Harland Sather; Michael E Trigg; R Chappell; D Hammond; Archie Bleyer
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):389-98.
1996: M Smith; D Arthur; Bruce M Camitta; Andrew J Carroll; William M Crist; Paul S Gaynon; R Gelber; N Heerema; Edward L Korn; Michael Link; S Murphy; Ching-Hon Pui; Jeanette Pullen; G Reamon; Stephen E Sallan; Harland Sather; J Shuster; Richard Simon; Michael E Trigg; DG Tubergen; fatih uckun; R Ungerleider
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):18-24.
1995: Paul S Gaynon
Acute leukemia in children.
Current opinion in hematology 1995;2(4):240-6.
1995: fatih uckun; Harland Sather; Gregory Reaman; J Shuster; V Land; Michael E Trigg; R Gunther; LM Chelstrom; A Bleyer; Paul S Gaynon
Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
Blood 1995;85(4):873-8.
1994: Lawrence J Ettinger; Paul S Gaynon; Mark Krailo; N Ru; E S Baum; Stuart E Siegel; G D Hammond
A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group.
Cancer 1994;73(4):1297-301.
1993: Joel M Cherlow; Peter G Steinherz; Harland Sather; Paul S Gaynon; N J Grossman; J H Kersey; Helen S Johnstone; John C. Breneman; Michael E Trigg; G D Hammond
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
International journal of radiation oncology, biology, physics 1993;27(5):1001-9.
1993: Paul S Gaynon; Peter G Steinherz; Archie Bleyer; A R Ablin; V C Albo; Jerry Z Finklestein; N J Grossman; L J Novak; A F Pyesmany; Gregory H Reaman
Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(11):2234-42.
1993: Lawrence J Ettinger; Mark Krailo; Paul S Gaynon; G D Hammond
A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group.
Cancer 1993;72(3):917-22.
1993: James B Nachman; Harland Sather; Jonathan D Buckley; Paul S Gaynon; Peter G Steinherz; DG Tubergen; BC Lampkin; G D Hammond
Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment.
Cancer 1993;71(10 Suppl):3377-85.
1991: Paul S Gaynon; Peter G Steinherz; Archie Bleyer; Jerry Z Finklestein; D R Miller; Gregory H Reaman; Harland Sather; G D Hammond
Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.
Medical and pediatric oncology 1991;19(4):221-7.
1991: A Kowal-Vern; F L Johnson; Yolanda Pinzon Trujillo; James B Nachman; J Radhakrishnan; P Conard; Paul S Gaynon
Granulocytic sarcoma of the ileum treated by bone marrow transplantation.
The American journal of pediatric hematology/oncology 1991;13(1):34-8.
1991: P M Zeltzer; K Epport; M D Nelson; K Huff; Paul S Gaynon
Prolonged response to carboplatin in an infant with brain stem glioma.
Cancer 1991;67(1):43-7.
1990: Paul S Gaynon; Lawrence J Ettinger; E S Baum; Stuart E Siegel; Mark Krailo; G D Hammond
Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
Cancer 1990;66(12):2465-9.
1990: Paul S Gaynon
Primary treatment of childhood acute lymphoblastic leukemia of non-T cell lineage (including infants).
Hematology/oncology clinics of North America 1990;4(5):915-36.
1990: Paul S Gaynon; Archie Bleyer; Peter G Steinherz; Jerry Z Finklestein; P Littman; D R Miller; Gregory Reaman; Harland Sather; G D Hammond
Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.
Medical and pediatric oncology 1990;18(4):273-9.
1988: Paul S Gaynon; Peter G Steinherz; Archie Bleyer; A R Ablin; V C Albo; Jerry Z Finklestein; N J Grossman; P S Littman; L T Novak; A F Pyesmany
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group.
Lancet 1988;2(8617):921-4.
1988: H S Maurer; Peter G Steinherz; Paul S Gaynon; Jerry Z Finklestein; Harland Sather; Gregory H Reaman; Archie Bleyer; G D Hammond
The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(9):1425-32.
1988: Paul S Gaynon; Archie Bleyer; Peter G Steinherz; Jerry Z Finklestein; P S Littman; D R Miller; Gregory H Reaman; Harland Sather; G D Hammond
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.
The American journal of pediatric hematology/oncology 1988;10(1):42-50.
1987: Paul S Gaynon; Lawrence J Ettinger; D Moel; Stuart E Siegel; E S Baum; W Krivit; G D Hammond
Pediatric phase I trial of carboplatin: a Childrens Cancer Study Group report.
Cancer treatment reports 1987;71(11):1039-42.
1987: Gregory H Reaman; Peter G Steinherz; Paul S Gaynon; Archie Bleyer; Jerry Z Finklestein; R Evans; D R Miller; Harland Sather; G D Hammond
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
Cancer treatment reports 1987;71(11):1033-8.
1987: Paul S Gaynon; E S Baum; C Samsel; Harland Sather
Microcomputer-assisted data management for multiinstitutional pediatric clinical cancer trials.
The American journal of pediatric hematology/oncology 1987;9(1):33-41.
1986: Peter G Steinherz; Paul S Gaynon; D R Miller; Gregory Reaman; A Bleyer; Jerry Z Finklestein; R G Evans; Paul A Meyers; L J Steinherz; Harland Sather
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(5):744-52.
1982: Paul S Gaynon; E S Baum; W Krivit; D Hammond
Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
Cancer treatment reports 1982;66(7):1583-4.
1981: E S Baum; Paul S Gaynon; L Greenberg; W Krivit; D Hammond
Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
Cancer treatment reports 1981;65(9-10):815-22.